Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Vps4aem1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Vps4aem1/Cya

Common Name
Vps4a-KO
Product ID
S-KO-20853
Backgroud
C57BL/6JCya
Strain ID
KOCMP-116733-Vps4a-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Vps4a-KO Mouse (Catalog S-KO-20853) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Vps4a-KO
Strain ID
KOCMP-116733-Vps4a-B6J-VA
Gene Name
Vps4a
Product ID
S-KO-20853
Gene Alias
4930589C15Rik
Background
C57BL/6JCya
Gene Full Name
vacuolar protein sorting 4A
Modification
Conventional knockout
NCBI ID
116733 (Mouse)
Phenotype
MGI:1890520
Chromosome
Chr 8 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000034388
NCBI Transcript ID
NM_126165
Target Region
Exon 4~5
Size of Effective Region
~1.4 kb
Overview of Gene Research
Vps4a, vacuolar-protein-sorting-associated protein 4A, is a member of the large family of AAA+ ATPases. It is a crucial component of the endosomal sorting complex required for transport (ESCRT) system, driving membrane remodeling in multiple cellular processes such as receptor degradation, cell division, and neural pruning [4]. It also has functions in regulating autophagy, lipophagy, and is involved in exosome-related processes [1,2,5].

In cardiomyocyte-specific Vps4a knockout mice, there was autophagosome accumulation, blocked autophagic flux, resulting in hypertrophic cardiomyopathy and early lethality, indicating Vps4a's role in autophagic flux regulation in cardiomyocytes [3]. In human studies, de novo missense variants in Vps4A caused multisystem disease with abnormal neurodevelopment, affecting various cellular processes like endosomal morphology, centrosome number regulation, and cell cycle progression [6]. Also, mutations in Vps4A led to syndromic congenital dyserythropoietic anemia due to cytokinesis and trafficking defects [7].

In conclusion, Vps4a is essential for membrane remodeling, autophagy, lipophagy, and exosome-related functions. The use of Vps4a knockout mouse models has revealed its significance in heart diseases such as hypertrophic cardiomyopathy, as well as in human disorders including abnormal neurodevelopment and congenital dyserythropoietic anemia. These studies help in understanding the underlying mechanisms of these diseases and may contribute to the development of new therapeutic strategies.

References:
1. Guo, Weina, Zhou, Haifeng, Wang, Jingbo, Luo, Shanshan, Hu, Desheng. 2024. Aloperine Suppresses Cancer Progression by Interacting with VPS4A to Inhibit Autophagosome-lysosome Fusion in NSCLC. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2308307. doi:10.1002/advs.202308307. https://pubmed.ncbi.nlm.nih.gov/39166458/
2. Das, Debajyoti, Sharma, Mridul, Gahlot, Deepanshi, Martinez-Lopez, Nuria, Singh, Rajat. 2024. VPS4A is the selective receptor for lipophagy in mice and humans. In Molecular cell, 84, 4436-4453.e8. doi:10.1016/j.molcel.2024.10.022. https://pubmed.ncbi.nlm.nih.gov/39520981/
3. Huang, Xiaozhi, Zhang, Jiayin, Wang, Wenyi, Huang, Zhishan, Han, Peidong. 2023. Vps4a Regulates Autophagic Flux to Prevent Hypertrophic Cardiomyopathy. In International journal of molecular sciences, 24, . doi:10.3390/ijms241310800. https://pubmed.ncbi.nlm.nih.gov/37445978/
4. Dvilansky, Inbar, Altaras, Yarin, Kamenetsky, Nikita, Nachmias, Dikla, Elia, Natalie. 2024. The human AAA-ATPase VPS4A isoform and its co-factor VTA1 have a unique function in regulating mammalian cytokinesis abscission. In PLoS biology, 22, e3002327. doi:10.1371/journal.pbio.3002327. https://pubmed.ncbi.nlm.nih.gov/38687820/
5. Han, Qingfang, Lv, Lihong, Wei, Jinxing, Liu, Peiqing, Min, Jun. 2019. Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. In Cancer letters, 457, 47-59. doi:10.1016/j.canlet.2019.04.035. https://pubmed.ncbi.nlm.nih.gov/31059752/
6. Rodger, Catherine, Flex, Elisabetta, Allison, Rachel J, Tartaglia, Marco, Reid, Evan. 2020. De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment. In American journal of human genetics, 107, 1129-1148. doi:10.1016/j.ajhg.2020.10.012. https://pubmed.ncbi.nlm.nih.gov/33186545/
7. Seu, Katie G, Trump, Lisa R, Emberesh, Sana, Lutzko, Carolyn M, Kalfa, Theodosia A. 2020. VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects. In American journal of human genetics, 107, 1149-1156. doi:10.1016/j.ajhg.2020.10.013. https://pubmed.ncbi.nlm.nih.gov/33186543/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research